From the beta-amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s Disease

The latest, on-demand Digital Dialogue from the Lab of the Future features world-renowned presenters with a case study of the application of AI to drive ground-breaking science. Register to attend

Dr. Rudolph Tanzi is, inter alia, Vice-Chair of Neurology at Massachusetts General Hospital and Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard Medical School

John Dwyer is President and Founding Board Member of the Global Alzheimer’s Platform Foundation

Colin Hill is CEO and Co-Founder, Aitia

This recorded session is part of the Lab of the Future premium content section. It is free for registered users. Please register or submit below